Amlodipine Market Outlook 2026-2034: by Formulation (Tablets, Capsules, Oral Solutions), Indication, Dosage Strength, Distribution Channel

The Amlodipine Market is estimated at US$412.8 million in 2026 and is projected to grow at a CAGR of 28.2% to reach US$3.01 billion by 2034.

Market Overview

The amlodipine market includes prescription cardiovascular therapy centered on amlodipine formulations used for blood pressure control and related cardiac management pathways. The value chain covers active ingredient sourcing, tablet formulation, generic manufacturing, distribution through wholesale and retail pharmacy channels, and prescriber-driven dispensing.

Key end uses include hypertension management, angina care, combination therapy regimens, and long-term cardiovascular risk control. At the same time, the market faces challenges related to intense generic price pressure, supply continuity concerns, and limited differentiation in mature prescription markets.

Market Segmentation

By Formulation

• Tablets
• Capsules
• Oral Solutions

By Indication

• Hypertension
• Coronary Artery Disease / Angina

By Dosage Strength

• mg
• 5 mg
• 10 mg

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Key Companies Analysed

• Pfizer Inc.
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Limited
• Dr. Reddy’s Laboratories Ltd.
• Aurobindo Pharma Limited
• Cipla Limited
• Lupin Limited
• Torrent Pharmaceuticals Ltd.
• Zydus Lifesciences Limited
• Apotex Inc.
• Sandoz Group AG
• Amneal Pharmaceuticals, Inc.
• Glenmark Pharmaceuticals Ltd.
• Alembic Pharmaceuticals Limited
• Wockhardt Ltd.
• Hikma Pharmaceuticals PLC
• Taro Pharmaceutical Industries Ltd.
• Strides Pharma Science Limited
• Beximco Pharmaceuticals Ltd.

Geographic Coverage

• North America - Market data and outlook to 2034
  • United States
  • Canada
  • Mexico
  
  
• Europe - Market data and outlook to 2034
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Poland
  • Sweden
  • Russia
  
  
• Asia-Pacific - Market data and outlook to 2034
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Vietnam
  
  
• Middle East and Africa - Market data and outlook to 2034
  • Saudi Arabia
  • South Africa
  • Iran
  • UAE
  • Egypt
  
  
• South and Central America - Market data and outlook to 2034
  • Brazil
  • Argentina
  • Chile
  • Peru
  
  

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

• Updated PDF report and an MS Excel workbook containing market tables and figures.
• 7-day post-sale analyst support for clarifications and in-scope supplementary data.
• Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.